Evidence map›Paper›PMID 38002641›Full record

ReviewJournal of clinical medicine2023

A Systematic Review and Illustrative Case Presentation of Low-Grade Myofibroblastic Sarcoma (LGMS) of the Extremities.

Astrid Schenker, Ewgenija Gutjahr, Burkhard Lehner, Gunhild Mechtersheimer, Eva Wardelmann, Rosa Klotz, Eva Kalkum, Marcus Schiltenwolf, Leila Harhaus, Tobias Renkawitz and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Astrid SchenkerDepartment for Orthopaedics, University of Heidelberg, Schlierbacher Landstraße 200a, 69118 Heidelberg, Germany.
Ewgenija GutjahrDepartment of Pathology, University of Heidelberg, 69120 Heidelberg, Germany.ORCID 0000-0003-2099-7306
Burkhard LehnerDepartment for Orthopaedics, University of Heidelberg, Schlierbacher Landstraße 200a, 69118 Heidelberg, Germany.
Gunhild MechtersheimerDepartment of Pathology, University of Heidelberg, 69120 Heidelberg, Germany.
Eva WardelmannGerhard Domagk Institute of Pathology, University Hospital Muenster, Albert-Schweitzer-Campus 1, Building D17, 48149 Muenster, Germany.ORCID 0000-0001-6788-4910
Rosa KlotzStudy Center of the German Society of Surgery (SDGC), University of Heidelberg, Im Neuenheimer Feld 130.3, 69120 Heidelberg, Germany.ORCID 0000-0003-4123-261X
Eva KalkumStudy Center of the German Society of Surgery (SDGC), University of Heidelberg, Im Neuenheimer Feld 130.3, 69120 Heidelberg, Germany.
Marcus SchiltenwolfDepartment for Orthopaedics, University of Heidelberg, Schlierbacher Landstraße 200a, 69118 Heidelberg, Germany.ORCID 0000-0003-0835-4172
Leila HarhausDepartment for Orthopaedics, University of Heidelberg, Schlierbacher Landstraße 200a, 69118 Heidelberg, Germany.
Tobias RenkawitzDepartment for Orthopaedics, University of Heidelberg, Schlierbacher Landstraße 200a, 69118 Heidelberg, Germany.
Benjamin PanzramDepartment for Orthopaedics, University of Heidelberg, Schlierbacher Landstraße 200a, 69118 Heidelberg, Germany.
Heidelberg University · DEGerman Society of Surgery · DEUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLow-grade myofibroblastic sarcoma (LGMS) is a rare tumor entity which occurs in the subcutaneous and deep soft tissues; it is less common in the bone with a predilection for the extremities and the head and neck region. As confirming the diagnosis is difficult and treatment strategies are not standardized, we aimed to identify patient and tumor characteristics, and to summarize treatment strategies and their clinical outcomes to guide surgeons.

methodsIncluded were full articles reporting patients with histology of LGMS in the extremities, excluding tumors of the trunk. All patients underwent surgery but with different extend, from marginal to wide resection. Included studies should inform about local recurrence, metastasis, or evidence of disease, depending on the surgical treatment. We conducted a structured search using MEDLINE (via PubMed), Web of Science, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) to identify studies on low-grade myofibroblastic sarcoma of the extremities. Study designs like randomized controlled trials, systematic reviews, prospective trials, retrospective studies, and case reports were included. Prospective studies and comparative studies were not available at all. Therefore, meta-analysis was not possible and statistical analysis was purely descriptive.

resultsOf the 789 studies identified from our initial search, 17 studies including 59 cases reported LGMS of the extremities with the surgical treatment and clinical outcome and were therefore analyzed. In addition, we present the rare case and surgical management of a 28-year-old male patient with residual LGMS of the thumb after an initial incomplete resection. The current literature suggests that a wide excision with R0 margins should be considered the standard treatment for LGMS. In cases where surgery leads to significant functional impairment, individual options like free tissue transfer from a donor site have to be considered. Therefore, we also present an illustrative case. For all selected case series and case reports, a high risk of confounding, selection bias, information bias, and reporting bias must be anticipated. Nevertheless, this systematic review provides a comprehensive overview on surgical treatment and clinical outcomes in LGMS surgery of the extremities.

Indexed as

Holevich’s flapLGMSmyofibrosarcomasoft tissue sarcomathumb reconstruction surgery

Identifiers

PMID38002641
PMCPMC10672639
OpenAlexW4388574501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.